A Stock Analysis: Buy, Sell, or Hold?
A - Agilent Technologies Inc.
$126.67
0.18 (0.14%)
▲
5d:
-3.0%
30d:
+10.35%
90d:
+13.08%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 26, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.2/10
Get Alerted When A Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: A shows positive signals but monitor for confirmation. Market pricing in 0.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: A shows positive signals but monitor for confirmation. Market pricing in 0.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$177.28
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$110.08
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: A is currently trading at $126.67, which is considered fair relative to its 30-day fair value range of $116.26 to $135.37. The stock's valuation (Forward PE: 19.1) is in line with its historical norms (19.6). Remarkably, the market is currently pricing in an annual earnings decline of 0.7% over the next few years. This pessimistic expectation contrasts with the company's recent 60.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, A is in a uptrend. The price is currently testing key support at $123.69. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $160.35 (+26.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, A is in a uptrend. The price is currently testing key support at $123.69. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $160.35 (+26.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$116.26 -
$135.37
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.8% below Wall St target ($160.35)
Trading Range Analysis
30-Day Trading Range
$116.26 -
$135.37
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$123.70
Resistance Level
$137.64
Current Trend
Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.15
Wall Street Target
$160.35
(+26.8%)
Revenue Growth (YoY)
10.0%
Earnings Growth (YoY)
60.0%
Profit Margin
19.6%
Valuation Discount vs History
-0.7% cheaper
PE vs Historical
19.2 vs 19.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.7%
(market-implied from PE analysis)
1-Year Target
$125.60
(-1%)
2-Year Target
$124.73
(-1%)
3-Year Target
$123.85
(-2%)
3-Yr Target (if PE normalizes)
(PE: 19→20)
$126.79
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 9.0%)
$186.53
(+48%)
Base:
(SPY PE: 19.1, Growth: 9.0%)
$163.98
(+30%)
Bear:
(PE: 16.3, Growth: 9.0%)
$139.38
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 25.51 | Current EPS (TTM): $4.98
Bull Case
$185.41
(+47%)
Analyst growth 32.7%, PE expands to 28.1
Base Case
$168.56
(+33%)
Market implied 32.7%, PE stable at 25.5
Bear Case
$86.40
(-32%)
Severe decline -20.0%, PE contracts to 21.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.1 to 19.6
Stabilization Target:
$129.49
(+2.4%)
PE Expansion Potential:
+2.4%
Share & Embed Analysis
Last updated: June 23, 2026 4:06 PM ET
Data refreshes hourly during market hours. Next update: 5:06 PM
Data refreshes hourly during market hours. Next update: 5:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is A showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Ro Khanna
BUY
2026-03-10
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 59 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 63 BUY |
Advanced A Option Strategies
Professional options setups generated by AI based on today's A price and gamma walls.
